The Endocrinology and Metabolism Research Training Program (T32) at Duke University Medical Center is centered on clinical and basic science investigators in the Division of Endocrinology, as well as collaborators working in other divisions and departments. The broad goal of this program is to train the next generation of biomedical scientists working in Diabetes, Metabolism and related diseases. Post-doctoral participants in this program will be either board- eligible or board-certified physicians with training in Internal Medicine or Pediatrics, or PhD scientists pursuing careers in endocrine/metabolic research. The Duke Endocrinology T32 has a long track record of training successful investigators in diabetes, metabolic bone disease, and other areas of endocrine/metabolic research. A substantial majority (80% of trainees over the past two cycles of the grant) are in academic positions at major medical centers across the US and abroad. Most are in positions with substantial research components, supported by federal, foundation, or industry grants, and the remainder have significant teaching responsibilities. The program includes training opportunities in clinical, translational, and basic research. Mentors associated with this grant have funded research programs ranging from basic science (islet biology, mitochondrial function and energetics, metabolic flux, transcriptional regulation of metabolism), to preclinical physiology using mouse genetic models, clinical physiology in humans (insulin secretion, incretin function, exercise and metabolism, bariatric surgery) to implementation science (novel approaches to diabetes care and weight management), and outcomes research (clinical trials and epidemiology). Trainees will choose primary mentors, but have access to the full breadth of the mentorship team through collaborations, didactic teaching and seminars. Training is aimed at identifying important research questions, formulating incisive hypotheses and learning to design simple but dispositive experiments; technical and analytic proficiency will also be stressed. Individuals who complete the program will be capable of independent investigation and able to translate research accomplishments into significant advances with clinical relevance.

Public Health Relevance

Diabetes and related conditions are a public health scourge, with a prevalence approaching 10% worldwide, causing significant complications and co-morbidities and enormous cost to health care systems. To meet the growing clinical needs of people affected by diabetes and other endocrine disorders, and to develop new and more effective treatments and therapeutic strategies, it is critical to train more academic Endocrinologists who have the capacity to assess and change the course of clinical diabetes through discovery, analysis, and development of new strategies. The Duke University T32 Research Training Program in Endocrinology and Metabolism has a mission to recruit and train outstanding physicians and other medical scientists for careers in endocrine/metabolic research in an outstanding multifaceted environment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007012-42
Application #
9937714
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1975-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
42
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Rhea, Elizabeth M; Salameh, Therese S; Gray, Sarah et al. (2018) Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptor. Mol Metab 18:88-96
Page, Laura C; Gastaldelli, Amalia; Gray, Sarah M et al. (2018) Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans. Diabetes 67:1976-1985
Douros, Jonathan D; Lewis, Alfor G; Smith, Eric P et al. (2018) Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a ?-Cell Glucagon-Like Peptide 1 Receptor. Diabetes 67:1504-1511
Wagner, Gregory R; Bhatt, Dhaval P; O'Connell, Thomas M et al. (2017) A Class of Reactive Acyl-CoA Species Reveals the Non-enzymatic Origins of Protein Acylation. Cell Metab 25:823-837.e8
Anderson, Kristin A; Huynh, Frank K; Fisher-Wellman, Kelsey et al. (2017) SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. Cell Metab 25:838-855.e15
Wagner, Gregory R; Hirschey, Matthew D (2017) A Prob(e)able Route to Lysine Acylation. Cell Chem Biol 24:126-128
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela A et al. (2016) Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. Endocrine 52:579-86
McVay, Megan A; Voils, Corrine I; Geiselman, Paula J et al. (2016) Food preferences and weight change during low-fat and low-carbohydrate diets. Appetite 103:336-343
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela et al. (2015) Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab 100:1529-36
Okorodudu, Daniel E; Bosworth, Hayden B; Corsino, Leonor (2015) Innovative interventions to promote behavioral change in overweight or obese individuals: A review of the literature. Ann Med 47:179-85

Showing the most recent 10 out of 57 publications